Open AccessCaspase-2 mRNA levels are not elevated in mild cognitive impairment, Alzheimer’s disease, Huntington’s disease, or Lewy Body dementia
Author(s) -
Chris Hlynialuk,
Lisa J. Kemper,
Kailee Lein-Wright,
Ronald C. Petersen,
Karen H. Ashe,
Benjamin R. Smith
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0274784
Subject(s) - dementia with lewy bodies , neurodegeneration , dementia , caspase 3 , messenger rna , alzheimer's disease , gene isoform , caspase 2 , caspase , biology , medicine , neuroscience , disease , endocrinology , apoptosis , gene , genetics , programmed cell death
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom